TY  - GEN
AU  - Macaluso,Fabio Salvatore
AU  - Fries,Walter
AU  - Viola,Anna
AU  - Centritto,Andrea
AU  - Cappello,Maria
AU  - Giuffrida,Enrica
AU  - Privitera,Antonino Carlo
AU  - Piccillo,Giovita
AU  - Magnano,Antonio
AU  - Vinci,Elisa
AU  - Vassallo,Roberto
AU  - Trovatello,Antonino
AU  - Belluardo,Nunzio
AU  - Giangreco,Emiliano
AU  - Camilleri,Salvatore
AU  - Garufi,Serena
AU  - Bertolami,Carmelo
AU  - Ventimiglia,Marco
AU  - Renna,Sara
AU  - Orlando,Rosalba
AU  - Rizzuto,Giulia
AU  - Orlando,Ambrogio
TI  - The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches
SN  - 1536-4844
PY  - 2022///0207
KW  - Biosimilar Pharmaceuticals
KW  - therapeutic use
KW  - Gastrointestinal Agents
KW  - Humans
KW  - Inflammatory Bowel Diseases
KW  - drug therapy
KW  - Infliximab
KW  - Prospective Studies
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Observational Study
UR  - https://doi.org/10.1093/ibd/izaa036
ER  -